Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

440 – Immune Response to Mpox in PWH and PrEP Users After Infection, but Not in Response to Vaccination

By Jimmy He PharmD, DScMarch 20, 2025

…median of 258(IQR 254-285) days ago; those vaccinated with one dose a median of 339 days ago(IQR 288-349) and those who received two doses 126(IQR 72-169) days ago. The median…

Could This Be Cell-Associated Perinatal HIV Transmission?

By Jimmy He PharmD, DScMarch 6, 2024

…(VL) near delivery; infant post-exposure prophylaxis (PEP); no breastfeeding. Despite fulfilling these criteria, we present two cases of vertical transmission from one UK centre and review the literature. Methods: Retrospective…

1051 – Impact of US Funding Shifts on HIV Care: A Rapid Survey of Clinics and Programs in 32 Countries

By Jimmy He PharmD, DScMarch 31, 2026

…in countries with active PEPFAR support (86%) at the beginning of 2025. Substantial proportions reported disruptions in HIV-related service delivery (47%), medication availability (28%), laboratory services (34%) and other clinic…

IMPLICATIONS OF CERVICAL CANCER SCREENING AND TREATMENT PROGRAM ROLL OUT IN UGANDA

By Jimmy He PharmD, DScMarch 3, 2023

Background: At 54.8 cases per 100,000 women, Uganda is one of the highest cervical cancer (CxCa) burdened countries in the world. Women living with HIV (WLHIV) are 6 times greater…

Lipid Composition and CXCR4 Decoration Facilitate HIV-1 CRISPR Delivery and Viral Excision

By Jimmy He PharmD, DScMarch 6, 2024

…from 4004 HIV-1 strains. CXCR4-targeting cyclic-peptide (CycPep) was conjugated with PEG-lipid to make DSPE-PEG-CycPep and LNP was formulated by microfluidic mixing. The specificity of the CXCR4 receptor was shown by…

REPROGRAMMING CMV-SPECIFIC CD8+ T CELLS TO TARGET HIV USING TCR GENE TRANSFER

By Jimmy He PharmD, DScMarch 3, 2023

…exhaustion. In contrast, chronic cytomegalovirus (CMV) infection induces a unique CTL response termed memory inflation characterized by continued expansion following priming, maintained “effector‐memory” phenotype, and sustained functionality. As T cell…

441 – MVA Vaccine Produces Potent Serologic and Immunologic Response to Mpox in People With HIV

By Jimmy He PharmD, DScMarch 20, 2025

…of immunosuppression (median CD4:931, IQR:394-892, CD8:515, IQR:393-892).  Plasma and PBMC samples from past-infection (PI) cohort (n=9, median age= 42, IQR=36-47) and vaccination (Vax) cohort (n=8, median age =41, IQR=41-53) were…

S mRNA PRIME S+N DNA BOOST VACCINATION ELICITS ROBUST IMMUNE RESPONSES IN MICE

By Jimmy He PharmD, DScApril 4, 2022

…IL-2 production in response to S-WT, S Delta variant and N protein overlapping peptides by intracellular cytokine staining (ICS). Splenocyte cytokine secretion upon stimulation with S-WT/N peptides was also assessed…

A NOVEL PHAGE-DISPLAY APPROACH MAPS LINEAR EPITOPES OF GP41-SPECIFIC MABs

By Enthusiast Inc MDMarch 6, 2019

…mapping methods. Here we developed and tested a high-throughput, comprehensive approach to map the epitopes of recently identified HIV-specific monoclonal antibodies (mAbs) that mediate ADCC. We applied a phage display…

CROI News

By Enthusiast Inc MDFebruary 15, 2020

…IAS-USA efforts. Read article IN MEMORIAM: Dr James G. Hakim It is with deep sadness that we learned of the death of Dr James G. Hakim. An acclaimed researcher and…

←1
234567891011121314151617181920212223242526272829
…3031323334…
353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top